Wealthcare Advisory Partners LLC Buys 97 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Wealthcare Advisory Partners LLC boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 4,004 shares of the medical equipment provider’s stock after acquiring an additional 97 shares during the quarter. Wealthcare Advisory Partners LLC’s holdings in Intuitive Surgical were worth $2,090,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also added to or reduced their stakes in ISRG. Mirador Capital Partners LP boosted its holdings in Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after buying an additional 50 shares during the period. Exome Asset Management LLC grew its position in shares of Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Consolidated Planning Corp grew its position in shares of Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after purchasing an additional 1,198 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its stake in Intuitive Surgical by 73.2% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 270,029 shares of the medical equipment provider’s stock valued at $132,657,000 after purchasing an additional 114,149 shares during the period. Finally, Czech National Bank lifted its holdings in Intuitive Surgical by 6.9% in the 4th quarter. Czech National Bank now owns 77,227 shares of the medical equipment provider’s stock worth $40,309,000 after purchasing an additional 4,970 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. BTIG Research lifted their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research report on Tuesday, November 26th. Robert W. Baird lifted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Truist Financial lifted their target price on Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 18th. Finally, Piper Sandler restated an “overweight” rating and set a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Trading Up 1.5 %

NASDAQ ISRG opened at $592.64 on Friday. The stock has a market cap of $211.09 billion, a PE ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $362.14 and a 12 month high of $597.68. The company’s 50-day moving average price is $540.66 and its 200-day moving average price is $498.77.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Buying and Selling

In other news, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Brian Edward Miller sold 2,553 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the transaction, the executive vice president now owns 7,066 shares in the company, valued at approximately $3,638,990. This represents a 26.54 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock valued at $25,012,927 over the last quarter. 0.80% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.